引用本文:张少杰,唐凤珠,王 瑢,班莫璐,黄兰诚,周 凯,林钻平,瞿申红,李东云.广西地区壮族正常听力人群线粒体基因12S rRNA的突变研究[J].中国临床新医学,2023,16(5):442-446.
【打印本页】   【下载PDF全文】   查看/发表评论  【EndNote】   【RefMan】   【BibTex】
←前一篇|后一篇→ 过刊浏览    高级检索
本文已被:浏览 1181次   下载 990 本文二维码信息
码上扫一扫!
分享到: 微信 更多
广西地区壮族正常听力人群线粒体基因12S rRNA的突变研究
张少杰,唐凤珠,王 瑢,班莫璐,黄兰诚,周 凯,林钻平,瞿申红,李东云
530021 南宁,广西壮族自治区人民医院(广西医学科学院)耳鼻咽喉头颈科(张少杰,唐凤珠,班莫璐,林钻平,瞿申红,李东云);530000 南宁,广西中医药大学附属瑞康医院耳鼻咽喉头颈外科(王 瑢,黄兰诚);545000 广西,柳州市工人医院耳鼻咽喉头颈外科(周 凯)
摘要:
[摘要] 目的 研究广西地区壮族正常听力人群线粒体基因12S rRNA的突变携带率以及突变特点,为临床防聋及治聋提供参考。方法 采用晶芯十五项遗传性耳聋基因检测试剂盒(微阵列芯片法)对广西地区150例壮族正常听力的受试者进行线粒体基因12S rRNA的2个突变位点检测,对确诊的阳性结果进行Sanger测序分析。结果 150例受试者中,检出线粒体基因12S rRNA 1555 A>G突变者1例(携带率为0.67%),经Sanger测序证实为1555 A>G突变,未发现1494C>T位点突变。结论 在广西地区壮族人群中开展线粒体基因12S rRNA突变筛查具有重要意义,可以为突变携带者及其母系亲属提供合理的用药指导、遗传咨询,是预防药物性聋的有效措施。
关键词:  耳聋基因  线粒体基因  12S rRNA
DOI:10.3969/j.issn.1674-3806.2023.05.05
分类号:R 764
基金项目:国家自然科学基金地区科学基金项目(编号:82060190);广西重点研发计划项目(编号:桂科AB17292089);广西医疗卫生适宜技术开发与推广应用项目(编号:S2017078,S201421_05);广西卫生健康委科研课题(编号:Z20170304,Z20170366,Z2016593,Z2014215)
A study on the mutations of mitochondrial gene 12S rRNA among Zhuang people with normal hearing in Guangxi region
ZHANG Shao-jie, TANG Feng-zhu, WANG Rong, et al.
Department of Otolaryngology Head and Neck, the People′s Hospital of Guangxi Zhuang Autonomous Region(Guangxi Academy of Medical Sciences), Nanning 530021, China
Abstract:
[Abstract] Objective To study the mutation carrying rate and characteristics of the mutation of mitochondrial gene 12S rRNA in Zhuang people with normal hearing in Guangxi region, so as to provide reference for clinical prevention and treatment of deafness. Methods Two mutation sites of mitochondrial gene 12S rRNA were detected in 150 cases of Zhuang people with normal hearing by using Crystal Core 15-Item Genetic Deafness Test Kit(Microarray Chip Method), a deafness gene mutation test kit. Sanger sequencing was performed on the positive results of the confirmed diagnosis. Results Among the 150 subjects, mitochondrial gene 12S rRNA 1555 A>G mutation was detected in one case and its carrying rate was 0.67%. The case was confirmed as having 1555 A>G mutation by Sanger sequencing, and no mutation was found at 1494C>T site. Conclusion It is of great significance to carry out mitochondrial gene 12S rRNA mutation screening among Zhuang people in Guangxi region, which can provide reasonable medication guidance and genetic counseling for mutation carriers and their maternal relatives, and is an effective measure to prevent drug-related deafness.
Key words:  Deafness gene  Mitochondrial gene  12S ribosomal ribonucleic acid(12S rRNA)